US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,785.02

+54.552.00%

Number of Gainers:3

Number of Losers:2

Number of Flat:- -

PE:- -

High:2,785.24

Open:2,747.96

Low:2,709.44

Close:2,730.47

Volume:5.68M

Turnover:115.11M

Market Cap:44.49B

Float Cap:41.55B

Loading ...

Teva Pharmaceutical Announces Major Senior Notes Financing

Daré Bioscience Lowers Stockholder Meeting Quorum Requirement to One-Third Voting Power

MannKind management to meet with Cantor

Daré Bioscience Posts H.C. Wainwright Investor Conference Presentation for On-Demand Viewing

Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes

Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio

MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management

THOMSON REUTERS

MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed

THOMSON REUTERS

MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology

THOMSON REUTERS

MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study

THOMSON REUTERS

MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales

THOMSON REUTERS

MannKind Corporation - to Have Representation on Rose Pharma Board of Directors

THOMSON REUTERS

Teva initiated with an Outperform at Leerink

Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer

Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib

THOMSON REUTERS

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

THOMSON REUTERS

Teva Pharmaceuticals : UBS Raises Target Price to $48 from $42

THOMSON REUTERS

Teva Announces Launch of Offering of Senior Notes

THOMSON REUTERS

Femasys registers to sell 28.12M shares of common stock for holders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2785.0151,"timestamp":1789156799999,"preClose":2730.4697,"halted":0,"volume":5680744,"delay":0,"changeRate":0.019977,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":54.54541,"latestTime":"09-11 16:00:00 EDT","open":2747.9634,"high":2785.2388,"low":2709.4424,"amount":115106407.669124,"amplitude":0.027759,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.656322,"peRate":69.731563,"turnoverRate":0.003956,"increases":3,"decrements":2,"flats":0,"marketCap":44494395808,"floatMarketCap":41546748035},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2785.2388,"amplitude":0.027759,"preClose":2730.4697,"low":2709.4424,"pbRate":"5.656322","latestPrice":2785.0151,"volume":5680744,"delay":0,"open":2747.9634,"prevYearClose":2379.9924,"prevWeekClose":2734.7136,"prevMonthClose":2714.4358,"prevQuarterClose":2562.5076,"fiveDayClose":2753.218,"twentyDayClose":2738.6797,"sixtyDayClose":2484.0588,"secType":"PLATE","market":"US","turnoverRate":0.003956,"peRate":69.731563,"marketCap":44494395808,"floatMarketCap":41546748035,"timestamp":1789156799999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":3,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666734574","title":"Teva Pharmaceutical Announces Major Senior Notes Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666734574","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666734574?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158804,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical ( ($TEVA) ) has shared an announcement. On September 10, 2026, Teva announced it had successfully priced approximately $4.9 bil...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-major-senior-notes-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/teva-pharmaceutical-announces-major-senior-notes-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU2324357040.USD","BK4585","BK4557","LU1983299246.USD","BK4559","BK4588","TEVA","BK4584","BK4596","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574383","title":"Daré Bioscience Lowers Stockholder Meeting Quorum Requirement to One-Third Voting Power","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574383?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:30","pubTimestamp":1789158651,"startTime":"0","endTime":"0","summary":"Daré Bioscience lowers stockholder meeting quorum requirement to one-third voting powerDaré Bioscience cut the stockholder-meeting quorum threshold to at least one-third of voting power from a majorit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL7Dhh6D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4007","DARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666711195","title":"MannKind management to meet with Cantor","url":"https://stock-news.laohu8.com/highlight/detail?id=2666711195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666711195?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:55","pubTimestamp":1789156512,"startTime":"0","endTime":"0","summary":"Meeting to be held in Boston on September 17 hosted by Cantor. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mannkind-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mannkind-management-to-meet-with-cantor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666526782","title":"Daré Bioscience Posts H.C. Wainwright Investor Conference Presentation for On-Demand Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666526782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666526782?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:55","pubTimestamp":1789124124,"startTime":"0","endTime":"0","summary":"Daré Bioscience posts H.C. Wainwright investor conference presentation for on-demand viewingDaré Bioscience posted an on-demand investor presentation for the H.C. Wainwright 28th Annual Global Investm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL58yrZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BCDF","SG9999014039.USD","BK4584","LU2210149790.SGD","SG9999014005.SGD","BK4585","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","DARE","BK4007","BK4588","IE00B3QW5Z07.USD","BK4112","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666627275","title":"Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666627275","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666627275?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:04","pubTimestamp":1789034640,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced its offering of approximately $4.9 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359281/0/en/teva-announces-successful-pricing-of-4-9-billion-equivalent-senior-notes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4156","TEVA","BK4584","LU1983299246.USD","BK4559","BK4585","BK4007","LU2324357040.USD","BK4596","BK4566","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535312","title":"Femasys Partners with CapexMD to Offer Financing for FemaSeed Fertility Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535312","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535312?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:04","pubTimestamp":1788959042,"startTime":"0","endTime":"0","summary":"Femasys partners with CapexMD to offer financing for FemaSeed fertility portfolioFemasys partnered with CapexMD to offer dedicated patient financing for its FemaSeed-led fertility portfolio.Financing ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLc5TGtl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","NDAQ","LU2095319765.USD","BK4584","SG9999014005.SGD","SG9999014013.SGD","BK4082","IE00BQXX3C00.GBP","BCDF","IE00BN0W2T93.GBP","BK4112","FEMY","IE00BGHQF748.EUR","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2210149790.SGD","BK4539","IE00BKPKM429.USD","SG9999014021.USD","BK4585","IE00B64PRP62.GBP","SG9999014039.USD","LU0314104364.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584094","title":"MannKind Partners with Rose Pharma on Inhaled Rapid-Acting GLP-1 Weight-Loss Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584094","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584094?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949853,"startTime":"0","endTime":"0","summary":"MannKind partners with Rose Pharma on inhaled rapid-acting GLP-1 weight-loss therapyMannKind entered a worldwide licensing and collaboration agreement with Rose Pharma to develop ROSE-010 Technosphere","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6Q2z0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BCDF","LU0314104364.USD","BK4584","LU2210149790.SGD","SG9999014021.USD","SG9999014005.SGD","BK4112","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","LU2095319765.USD","NDAQ","MNKD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","BK4139","BK4588","IE00BQXX3F31.USD","IE00BGHQF748.EUR","BK4585","SG9999014039.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858406","title":"MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration Glp-1 for Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858406?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666840665","title":"MannKind Corporation: Specific Financial Terms of Agreement were not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2666840665","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666840665?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584063","title":"MannKind Corporation - Rose Pharma Receives Exclusive Worldwide License for Technosphere Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584063?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584062","title":"MannKind Corporation - to Provide Development and Manufacturing Support Through Phase 1B in Weight Management Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584062","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584062?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","MNKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258405","title":"MannKind Corporation - to Receive Equity Interest in Rose Pharma and Potential Royalties on Future Net Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258405","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258405?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666061584","title":"MannKind Corporation - to Have Representation on Rose Pharma Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666061584","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666061584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:30","pubTimestamp":1788949800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7JNY9J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","BK4139","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584165","title":"Teva initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584165?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948675,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Teva (TEVA) with an Outperform rating and $45 price target Published first on TheFly – the ultimate source for real-t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEVA","BK4584","BK4566","BK4585","BK4557","LU2324357040.USD","BK4559","BK4588","BK4596","LU1983299246.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320219","title":"Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320219","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320219?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869844,"startTime":"0","endTime":"0","summary":"Veru plans Phase 2 trial of oral sabizabulin in daraxonrasib-resistant metastatic pancreatic cancerVeru will advance oral sabizabulin into a planned Phase 2 trial for metastatic KRAS-driven pancreatic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLlxV4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","NDAQ","IE00BN0W2T93.GBP","BK4183","LU2095319765.USD","BK4588","BK4584","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4585","BK4557","BCDF","SG9999014039.USD","IE00BQXX3F31.USD","BK4112","VERU","IE00BQXX3D17.EUR","SG9999014005.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665296320","title":"Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2665296320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665296320?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4183","VERU","BK4584","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665202933","title":"Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665202933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665202933?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4584","VERU","BK4557","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665039080","title":"Teva Pharmaceuticals : UBS Raises Target Price to $48 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2665039080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665039080?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:01","pubTimestamp":1788768098,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nAZN4TIONZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","TEVA","BK4007","BK4566","LU1983299246.USD","BK4557","BK4584","BK4585","LU2324357040.USD","BK4596","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397717","title":"Teva Announces Launch of Offering of Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397717?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:53","pubTimestamp":1788767586,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUA6GXFN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4588","BK4559","LU1983299246.USD","BK4557","BK4007","LU2324357040.USD","BK4585","BK4596","TEVA","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664041728","title":"Femasys registers to sell 28.12M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2664041728","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664041728?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:10","pubTimestamp":1788469816,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 28.12M shares of common stock. The company is not ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-registers-to-sell-28-12m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-registers-to-sell-28-12m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","FEMY","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}